Kura Oncology, Inc. (KURA)
NASDAQ·Healthcare·Biotechnology
$8.87
-2.21%
Mkt Cap $817.93M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $35.43M | $17.34M | -51.07% | -$0.72 | -$0.92 | -27.78% | — | — |
| Q4 2025 Nov 4, 2025 | $51.43M | $20.75M | -59.65% | -$0.57 | -$0.85 | -49.12% | — | — |
| Q3 2025 Aug 7, 2025 | $64.95M | $15.29M | -76.46% | $0.15 | -$0.75 | -600.00% | — | — |
| Q2 2025 May 1, 2025 | $66.66M | $14.11M | -78.84% | -$0.51 | -$0.66 | -29.41% | — | — |
| Q1 2025 Feb 26, 2025 | $57.96M | $53.88M | -7.04% | -$0.65 | -$0.22 | +66.15% | — | — |
| Q4 2024 Nov 7, 2024 | $57.96M | — | — | -$0.64 | -$0.63 | +1.56% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.63 | -$0.59 | +6.35% | — | — |
| Q2 2024 May 2, 2024 | — | — | — | -$0.56 | -$0.59 | -5.36% | — | — |
| Q1 2024 Feb 27, 2024 | — | $1.27M | — | -$0.56 | -$0.55 | +1.79% | — | — |
| Q4 2023 Nov 2, 2023 | — | — | — | -$0.56 | -$0.50 | +10.71% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$0.57 | -$0.53 | +7.02% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$0.54 | -$0.50 | +7.41% | — | — |
| Q1 2023 Feb 23, 2023 | — | — | — | -$0.58 | -$0.49 | +15.52% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.57 | -$0.53 | +7.02% | — | — |
| Q3 2022 Aug 3, 2022 | — | — | — | -$0.52 | -$0.52 | +0.00% | — | — |
| Q2 2022 May 4, 2022 | — | — | — | -$0.52 | -$0.49 | +5.77% | — | — |
| Q1 2022 Feb 24, 2022 | — | — | — | -$0.54 | -$0.49 | +9.26% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$0.54 | -$0.50 | +7.41% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$0.49 | -$0.51 | -4.08% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.42 | -$0.46 | -9.52% | — | — |